| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jul―30 |
Cost-effectiveness analysis of nirmatrelvir/ritonavir in adult patients at high risk of progressing to severe COVID-19 |
Carolina Moreno, Andrea Aiello, Roberto Di Virgilio, Valentina Mazzotta, Andrea Antinori |
| 2 |
[GO] |
2025―Jul―17 |
Cost-effectiveness analysis of nirmatrelvir/ritonavir in adult patients at high risk of progressing to severe COVID-19 |
Carolina Moreno, Andrea Aiello, Roberto Di Virgilio, Valentina Mazzotta, Andrea Antinori |
| 3 |
[GO] |
2023―May―31 |
COVID-19 impact on the decision process of the Italian Medicine Agency: a quantitative assessment |
Beatrice Canali, Laura Candelora, Francesca Fiorentino, Tom Halmos, Paola La Malfa, Francesca Massara, Chiara Vassallo, Duccio Urbinati |
| 4 |
[GO] |
2021―Oct―25 |
Evaluation of epidemiological and economic consequences due to the delay in treatment of hiv-positive patients caused by the covid-19 pandemic |
Andrea Marcellusi, Chiara Bini, Massimo Andreoni, Andrea Antinori, Francesco Saverio Mennini |
| 5 |
[GO] |
2021―May―04 |
Author's reply to: Letter to Editor commenting "Continuity of care between hospital pharmacies and community pharmacies, and costs avoided: a pilot experience in times of COVID-19 in Spain" |
Néboa Zozaya |
| 6 |
[GO] |
2021―May―04 |
Correspondence to article "Continuity of care between hospital pharmacies and community pharmacies, and costs avoided: a pilot experience in times of COVID-19 in Spain" |
David Gomez |
| 7 |
[GO] |
2021―Feb―18 |
Continuity of care between hospital pharmacies and community pharmacies, and costs avoided: a pilot experience in times of COVID-19 in Spain |
Néboa Zozaya, Almudena González-Domínguez, Natividad Calvente, Rita De la Plaza, Ana Herranz, Antonio Blanes, Miguel Tamayo |
